🚀 VC round data is live in beta, check it out!
Tactile Medical Valuation Multiples
Discover revenue and EBITDA valuation multiples for Tactile Medical and similar public comparables like Anteris Technologies US, Beta Bionics, Cytek Biosciences, Mesa Laboratories and more.
Tactile Medical Overview
About Tactile Medical
Tactile Systems Technology Inc is a medical technology company. The company is engaged in developing and providing medical devices for the treatment of chronic diseases. The firm's proprietary platform flexitouch system, provides a home-based solution for lymphedema patients. The entire system is another home solution for patients with chronic swelling and actitouch system for chronic venous insufficiency patients that may be worn throughout the day.
Founded
1995
HQ
Employees
1.1K
Website
Financials (LTM)
EV
$502M
Tactile Medical Financials
Tactile Medical reported last 12-month revenue of $339M and EBITDA of $46M.
In the same LTM period, Tactile Medical generated $257M in gross profit, $46M in EBITDA, and $21M in net income.
Revenue (LTM)
Tactile Medical P&L
In the most recent fiscal year, Tactile Medical reported revenue of $330M and EBITDA of $45M.
Tactile Medical expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $339M | XXX | $330M | XXX | XXX | XXX |
| Gross Profit | $257M | XXX | $250M | XXX | XXX | XXX |
| Gross Margin | 76% | XXX | 76% | XXX | XXX | XXX |
| EBITDA | $46M | XXX | $45M | XXX | XXX | XXX |
| EBITDA Margin | 14% | XXX | 14% | XXX | XXX | XXX |
| EBIT Margin | 9% | XXX | 9% | XXX | XXX | XXX |
| Net Profit | $21M | XXX | $19M | XXX | XXX | XXX |
| Net Margin | 6% | XXX | 6% | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Tactile Medical Stock Performance
Tactile Medical has current market cap of $585M, and enterprise value of $502M.
Market Cap Evolution
Tactile Medical's stock price is $25.73.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $502M | $585M | 0.0% | XXX | XXX | XXX | $0.84 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialTactile Medical Valuation Multiples
Tactile Medical trades at 1.5x EV/Revenue multiple, and 10.9x EV/EBITDA.
EV / Revenue (LTM)
Tactile Medical Financial Valuation Multiples
As of April 19, 2026, Tactile Medical has market cap of $585M and EV of $502M.
Equity research analysts estimate Tactile Medical's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Tactile Medical has a P/E ratio of 27.7x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $585M | XXX | $585M | XXX | XXX | XXX |
| EV (current) | $502M | XXX | $502M | XXX | XXX | XXX |
| EV/Revenue | 1.5x | XXX | 1.5x | XXX | XXX | XXX |
| EV/EBITDA | 10.9x | XXX | 11.2x | XXX | XXX | XXX |
| EV/EBIT | 16.4x | XXX | 17.1x | XXX | XXX | XXX |
| EV/Gross Profit | 2.0x | XXX | 2.0x | XXX | XXX | XXX |
| P/E | 27.7x | XXX | 30.7x | XXX | XXX | XXX |
| EV/FCF | — | XXX | 12.5x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Tactile Medical Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Tactile Medical Margins & Growth Rates
Tactile Medical's revenue in the last 12 month grew by 9%.
Tactile Medical's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.2M for the same period.
Tactile Medical's rule of 40 is 23% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Tactile Medical's rule of X is 37% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Tactile Medical Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 9% | XXX | 9% | XXX | XXX | XXX |
| EBITDA Margin | 14% | XXX | 14% | XXX | XXX | XXX |
| EBITDA Growth | 13% | XXX | 10% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 23% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 37% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.3M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.2M | XXX | XXX | XXX |
| S&M Expenses to Revenue | 37% | XXX | 37% | XXX | XXX | XXX |
| G&A Expenses to Revenue | 27% | XXX | 27% | XXX | XXX | XXX |
| R&D Expenses to Revenue | 3% | XXX | 3% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 67% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Tactile Medical Public Comps
See public comps and valuation multiples for other Medical Devices comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Tactile Medical | XXX | XXX | XXX | XXX | XXX | XXX |
| Anteris Technologies US | XXX | XXX | XXX | XXX | XXX | XXX |
| Beta Bionics | XXX | XXX | XXX | XXX | XXX | XXX |
| Cytek Biosciences | XXX | XXX | XXX | XXX | XXX | XXX |
| Mesa Laboratories | XXX | XXX | XXX | XXX | XXX | XXX |
| Lumibird | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Tactile Medical M&A Activity
Tactile Medical acquired XXX companies to date.
Last acquisition by Tactile Medical was on XXXXXXXX, XXXXX. Tactile Medical acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Tactile Medical
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialTactile Medical Investment Activity
Tactile Medical invested in XXX companies to date.
Tactile Medical made its latest investment on XXXXXXXX, XXXXX. Tactile Medical invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Tactile Medical
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Tactile Medical
| When was Tactile Medical founded? | Tactile Medical was founded in 1995. |
| Where is Tactile Medical headquartered? | Tactile Medical is headquartered in United States. |
| How many employees does Tactile Medical have? | As of today, Tactile Medical has over 1K employees. |
| Who is the CEO of Tactile Medical? | Tactile Medical's CEO is Sheri Louise Dodd. |
| Is Tactile Medical publicly listed? | Yes, Tactile Medical is a public company listed on Nasdaq. |
| What is the stock symbol of Tactile Medical? | Tactile Medical trades under TCMD ticker. |
| When did Tactile Medical go public? | Tactile Medical went public in 2016. |
| Who are competitors of Tactile Medical? | Tactile Medical main competitors are Anteris Technologies US, Beta Bionics, Cytek Biosciences, Mesa Laboratories. |
| What is the current market cap of Tactile Medical? | Tactile Medical's current market cap is $585M. |
| What is the current revenue of Tactile Medical? | Tactile Medical's last 12 months revenue is $339M. |
| What is the current revenue growth of Tactile Medical? | Tactile Medical revenue growth (NTM/LTM) is 9%. |
| What is the current EV/Revenue multiple of Tactile Medical? | Current revenue multiple of Tactile Medical is 1.5x. |
| Is Tactile Medical profitable? | Yes, Tactile Medical is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Tactile Medical? | Tactile Medical's last 12 months EBITDA is $46M. |
| What is Tactile Medical's EBITDA margin? | Tactile Medical's last 12 months EBITDA margin is 14%. |
| What is the current EV/EBITDA multiple of Tactile Medical? | Current EBITDA multiple of Tactile Medical is 10.9x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.